Novus Biologicals products are now on bio-techne.com

Recombinant Human CCL18/PARC Protein, CF

Images

 
There are currently no images for CCL18/PARC (394-PA/CF).

Every product we sell is backed by Novus' 100% Guarantee. If you have used this product, please submit your images and reviews to earn reward points.

Product Details

Summary
Reactivity HuSpecies Glossary
Applications Bioactivity
Format
Carrier-Free

Order Details

View Available Formulations
Catalog# & Formulation Size Price
Novus Biologicals is part of Bio-Techne

Shop this product on bio-techne.com

Recombinant Human CCL18/PARC Protein, CF Summary

Details of Functionality
Measured by its ability to inhibit Eotaxin-induced chemotaxis of BaF3 mouse pro‑B cells transfected with human CCR3. Nibbs, RJB. et al. (2000) J. Immunol. 164:1488. The ED50 for this effect is 1-5 µg/mL.
Source
E. coli-derived human CCL18/PARC protein
Ala21-Ala89
Accession #
N-terminal Sequence
Ala21
Protein/Peptide Type
Recombinant Proteins
Gene
CCL18
Purity
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Note
<0.01 EU per 1 μg of the protein by the LAL method.

Applications/Dilutions

Dilutions
  • Bioactivity
Theoretical MW
7.8 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Publications
Read Publications using
394-PA/CF in the following applications:

Packaging, Storage & Formulations

Storage
  • 12 months from date of receipt, ≤ -20 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, ≤ -20 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in Acetonitrile with Trehalose.
Purity
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Reconstitution Instructions
Reconstitute at 100 μg/mL in sterile PBS.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Recombinant Human CCL18/PARC Protein, CF

  • Alternative macrophage activation-associated CC chemokine 1
  • AMAC-1
  • AMAC1CC chemokine ligand 18
  • AMAC-1Small-inducible cytokine A18
  • CCL18
  • chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
  • CKb7
  • DC-CK1
  • DC-CK1CC chemokine PARC
  • DCCK1Macrophage inflammatory protein 4
  • Dendritic cell chemokine 1
  • MIP4
  • MIP-4
  • MIP-4C-C motif chemokine 18
  • PARC
  • PARCPulmonary and activation-regulated chemokine
  • SCYA18chemokine (C-C), dendritic
  • small inducible cytokine A18
  • small inducible cytokine subfamily A (Cys-Cys), member 18, pulmonary andactivation-regulated

Background

CCL18, also known as alternative macrophage activation-associated CC chemokine (AMAC)-1, macrophage inflammatory protein (MIP)-4, and dendritic cell chemokine (DC-CK1), is a novel CC chemokine that is highly homologous to MIP-1 alpha (61% amino acid (aa) sequence identity). CCL18 cDNA encodes an 89 aa residue precursor protein with a 20 aa putative signal peptide that is cleaved to generate a 69 aa residue mature protein which lacks potential glycosylation sites. In vitro, CCL18 mRNA expression is induced in alternatively activated macrophages by Th2 cytokines such as IL-4, IL-10 and IL-13, and inhibited by IFN‑ gamma . CCL18 mRNA is also expressed by GM‑CSF/IL‑4‑induced monocyte-derived dendritic cells. In vivo, CCL18 is highly expressed in lung and placenta but is not expressed in epidermal Langerhans cells. Recombinant CCL18 has been shown to chemoattract naive T cells, but not monocytes or neutrophils.

  1. Adema, G. et al. (1997) Nature 387:713.
  2. Kodelja, V. et al. (1998) J. Immunol. 160:141.

Customers Who Viewed This Item Also Viewed...

NBP1-86928
Species: Hu
Applications: IHC, IHC-P, WB
DCP00
Species: Hu
Applications: ELISA
6507-IL/CF
Species: Hu
Applications: BA
DY417
Species: Mu
Applications: ELISA
M6000B
Species: Mu
Applications: ELISA
MAB208
Species: Hu
Applications: CyTOF-ready, ELISA(Cap), ELISA(Det), ELISA(Sta), ICC, ICFlow, Neut, Simple Western, WB
MCC170
Species: Mu
Applications: ELISA
DRN00B
Species: Hu
Applications: ELISA
NBP1-72042
Species: Hu, Mu, Rt
Applications: ICC/IF, IHC, IHC-P, PEP-ELISA, WB
DMD00
Species: Hu
Applications: ELISA
MMA00
Species: Mu
Applications: ELISA
NBP2-67232
Species: Hu, Mu
Applications: ICC/IF, IHC, IHC-P, WB
DM3A00
Species: Hu
Applications: ELISA
440-M3
Species: Mu
Applications: BA, BA
DIP100
Species: Hu
Applications: ELISA
MME00
Species: Mu
Applications: ELISA
DY327
Species: Hu
Applications: ELISA
AF-492-NA
Species: Mu
Applications: ELISA(Cap), ELISA(Det), ELISA(Sta), Neut
394-PA/CF
Species: Hu
Applications: Bioactivity

Publications for CCL18/PARC (394-PA/CF)(11)

We have publications tested in 3 confirmed species: Human, Mouse, Virus.

We have publications tested in 4 applications: Binding Assay, Bioassay, ELISA (Standard), In Vivo.


Filter By Application
Binding Assay
(1)
Bioassay
(8)
ELISA (Standard)
(2)
In Vivo
(2)
All Applications
Filter By Species
Human
(6)
Mouse
(2)
Virus
(1)
All Species
Showing Publications 1 - 10 of 11. Show All 11 Publications.
Publications using 394-PA/CF Applications Species
Y Huang, E Motta, C Nanvuma, LD Kuhrt, Y Yuan, P Xia, M Lubas, S Zhu, M Schnauss, N Qazi, F Hu, H Zhang, T Lei, M Synowitz, C Flüh, H Kettenmann Microglia/macrophage-derived human CCL18 promotes glioma progression via CCR8-ACP5 axis analyzed in humanized slice model Cell Reports, 2022-04-12;39(2):110670. 2022-04-12 [PMID: 35417708] (Bioassay, In Vivo, Mouse) Bioassay, In Vivo Mouse
K Jamal Jame, WJ Gallert, SD Yanik, S Panek, J Kronsbein, D Jungck, A Koch, J Knobloch Biomarkers for Comorbidities Modulate the Activity of T-Cells in COPD International Journal of Molecular Sciences, 2021-07-02;22(13):. 2021-07-02 [PMID: 34281240] (Bioassay, Human) Bioassay Human
L Amniai, C Ple, M Barrier, P de Nadai, P Marquillie, H Vorng, C Chenivesse, A Tsicopoulo, C Duez Natural Killer Cells from Allergic Donors Are Defective in Their Response to CCL18 Chemokine International Journal of Molecular Sciences, 2021-04-09;22(8):. 2021-04-09 [PMID: 33918621] (Bioassay, Human) Bioassay Human
Y Barsheshet, G Wildbaum, E Levy, A Vitenshtei, C Akinseye, J Griggs, SA Lira, N Karin CCR8(+)FOXp3(+) Treg cells as master drivers of immune regulation Proc. Natl. Acad. Sci. U.S.A., 2017-05-22;0(0):. 2017-05-22 [PMID: 28533380] (Bioassay, Human) Bioassay Human
Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, Ribas A, Li J, Moffat J, Sutherlin DP, Koeppen H, Merchant M, Neve R, Settleman J Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature, 2012-07-26;487(7408):505-9. 2012-07-26 [PMID: 22763448] (Bioassay, Human) Bioassay Human
Deegan PB, Pavlova E, Tindall J Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy. Medicine (Baltimore), 2011-01-01;90(1):52-60. 2011-01-01 [PMID: 21200186] (ELISA (Standard)) ELISA (Standard)
Pavlova EV, Deegan PB, Tindall J, McFarlane I, Mehta A, Hughes D, Wraith JE, Cox TM Potential biomarkers of osteonecrosis in Gaucher disease. Blood Cells Mol. Dis., 2010-11-13;46(1):27-33. 2010-11-13 [PMID: 21075651] (ELISA (Standard)) ELISA (Standard)
Leick M, Catusse J, Follo M, Nibbs RJ, Hartmann TN, Veelken H, Burger M CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B. Immunology, 2009-12-02;129(4):536-46. 2009-12-02 [PMID: 20002784] (Bioassay, Human) Bioassay Human
Nakayama T, Shirane J, Hieshima K, Shibano M, Watanabe M, Jin Z, Nagakubo D, Saito T, Shimomura Y, Yoshie O Novel antiviral activity of chemokines. Virology, 2006-04-17;350(2):484-92. 2006-04-17 [PMID: 16603217] (Binding Assay, Bioassay, Virus) Binding Assay, Bioassay Virus
Gunther C, Bello-Fernandez C, Kopp T, Kund J, Carballido-Perrig N, Hinteregger S, Fassl S, Schwarzler C, Lametschwandtner G, Stingl G, Biedermann T, Carballido JM CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells. J. Immunol., 2005-02-01;174(3):1723-8. 2005-02-01 [PMID: 15661937] (In Vivo, Mouse) In Vivo Mouse
Show All 11 Publications.

Reviews for CCL18/PARC (394-PA/CF) (0)

There are no reviews for CCL18/PARC (394-PA/CF). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen

FAQs for CCL18/PARC (394-PA/CF) (0)

There are no specific FAQs related to this product. Read our general customer & technical service FAQs.

Additional CCL18/PARC Products

Blogs on CCL18/PARC

There are no specific blogs for CCL18/PARC, but you can read our latest blog posts.

Customers Who Bought This Also Bought

Contact Information

Product PDFs

Calculators

Concentration Calculator

The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.

=
÷

Review this Product

Be the first to review our Recombinant Human CCL18/PARC Protein, CF and receive a gift card or discount.

Bioinformatics

Gene Symbol CCL18
Uniprot